Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dermira Inc (DERM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 506,089
  • Shares Outstanding, K 53,668
  • Annual Sales, $ 42,340 K
  • Annual Income, $ -221,540 K
  • 60-Month Beta 1.40
  • Price/Sales 12.64
  • Price/Cash Flow N/A
  • Price/Book 7.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.90
  • Number of Estimates 3
  • High Estimate -0.68
  • Low Estimate -1.07
  • Prior Year -0.57
  • Growth Rate Est. (year over year) -57.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.88 +6.19%
on 06/05/19
10.82 -12.85%
on 05/17/19
-1.03 (-9.85%)
since 05/14/19
3-Month
6.74 +39.91%
on 03/15/19
15.48 -39.08%
on 04/08/19
+2.52 (+36.47%)
since 03/14/19
52-Week
6.00 +57.17%
on 01/25/19
15.48 -39.08%
on 04/08/19
-0.57 (-5.70%)
since 06/14/18

Most Recent Stories

More News
Shares of Intra-Cellular T Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (ITCI , DERM , LLY , BMY , MDCO )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

DERM : 9.43 (-5.42%)
ITCI : 12.51 (-2.57%)
LLY : 111.74 (-0.07%)
Dermira to Present at the Raymond James Life Sciences and MedTech Conference

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients...

DERM : 9.43 (-5.42%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (COLL , DERM , PCRX , MNK , AGN )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

COLL : 12.05 (-1.23%)
DERM : 9.43 (-5.42%)
PCRX : 43.66 (-0.95%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (LCI , MDCO , DERM , MRK , CTLT )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

DERM : 9.43 (-5.42%)
LCI : 5.22 (-4.74%)
MDCO : 35.28 (-1.62%)
Relatively Good Performance Detected in Shares of Aerie Pharmaceut in the Pharmaceuticals Industry (AERI , DERM , MNK , HZNP , XENT )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

DERM : 9.43 (-5.42%)
AERI : 31.72 (-4.26%)
MNK : 9.28 (-5.79%)
Dermira (DERM) Reports Q1 Loss, Lags Revenue Estimates

Dermira (DERM) delivered earnings and revenue surprises of -13.74% and -6.77%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

DERM : 9.43 (-5.42%)
Dermira: 1Q Earnings Snapshot

MENLO PARK, Calif. (AP) _ Dermira Inc. (DERM) on Tuesday reported a loss of $64.8 million in its first quarter.

DERM : 9.43 (-5.42%)
Dermira Reports First Quarter 2019 Financial Results and Provides Corporate Update

--First quarter net product sales of $2.5 million

DERM : 9.43 (-5.42%)
Shares of Lannett Co Inc Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (LCI , HZNP , DERM , CTLT , SUPN )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

DERM : 9.43 (-5.42%)
LCI : 5.22 (-4.74%)
HZNP : 22.81 (-3.35%)
Relatively Good Performance Detected in Shares of Merck & Co in the Pharmaceuticals Industry (MRK , BMY , DERM , NKTR , PRGO )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

DERM : 9.43 (-5.42%)
MRK : 82.78 (-0.14%)
BMY : 47.56 (+0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade DERM with:

Business Summary

Dermira, Inc. is a specialty biopharmaceutical company. It is focused on bringing medical dermatology products to dermatologists and their patients. The Company markets topical small molecule therapeutics that target acne, sebaceous gland hyperactivity, and inflammatory skin diseases. Its late-stage...

See More

Key Turning Points

2nd Resistance Point 10.19
1st Resistance Point 9.81
Last Price 9.43
1st Support Level 9.20
2nd Support Level 8.97

See More

52-Week High 15.48
Fibonacci 61.8% 11.86
Fibonacci 50% 10.74
Fibonacci 38.2% 9.62
Last Price 9.43
52-Week Low 6.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar